<?xml version="1.0" encoding="UTF-8"?>
<list list-type="simple" continued-from="list5" id="list6">
 <list-item>
  <label>68</label>
  <p>What is the most plausible way for a range of non-state actors to generate a biological threat in the UK?</p>
 </list-item>
 <list-item>
  <label>69</label>
  <p>How could new technologies aid monitoring and verification of biological weapons development, production, and use?</p>
 </list-item>
 <list-item>
  <label>70</label>
  <p>What are the implications of intangible technology, such as tacit knowledge and the accessibility of the knowledge base, for enabling misuse?</p>
 </list-item>
 <list-item>
  <label>71</label>
  <p>What are the driving forces likely to lead to the use of biological and toxin weapons in the coming decades (e.g. advances in science and technology, the changing nature of warfare and the decline in the use of multilateral agreements), and how might these forces best be countered?</p>
 </list-item>
 <list-item>
  <label>72</label>
  <p>How do we assess the impact of the development of different intersecting technologies the potential for misuse?</p>
 </list-item>
 <list-item>
  <label>73</label>
  <p>What are the most effective interventions that the UK can take to mitigate the dark web becoming a technological vector for biological security threats?</p>
 </list-item>
 <list-item>
  <label>74</label>
  <p>What new means might be developed to make the operations of the BTWC more effective, and how can the impact of these changes be assessed?</p>
 </list-item>
 <list-item>
  <label>75</label>
  <p>How effective, transparent and timely are the mechanisms in the UK for monitoring and controlling research with potential for dual use?</p>
 </list-item>
 <list-item>
  <label>76</label>
  <p>What types of governance measures are most appropriate at different stages of technology development (from initial research through to product)?</p>
 </list-item>
 <list-item>
  <label>77</label>
  <p>What constitutes dual use research in the UK, how do we determine it, and who decides?</p>
 </list-item>
 <list-item>
  <label>78</label>
  <p>What guiding principles would be required to balance the benefits of scientific research with the responsibility to prohibit and prevent the development and acquisition of biological weapons?</p>
 </list-item>
 <list-item>
  <label>79</label>
  <p>What methods are effective in engaging wider communities when the research proposed or being conducted raises significant dual use issues? Do these methods differ between public and private settings?</p>
 </list-item>
 <list-item>
  <label>80</label>
  <p>What types of proportionate and adaptive governance systems, and assessment procedures, need to be in place to address dual use research concerns and ensure a balance between benefits and risks?</p>
 </list-item>
</list>
